Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
May 5, 2025
Ensuring oxygen access is essential to achieving health for all
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. The looming antibiotic emergency and why the time for global action is now
    PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  2. PATH part of $12.7M GHIT Fund initiative for malaria, NTDs research.
    PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
  3. Opinion: GenAI for global health — the bear and the bull case
    Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  4. Life-saving advances in vaccines pave the way for healthier futures
    Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

952 Item s
952 Item s
    Date
    From
    To
  1. PATH welcomes remarkable results from clinical trial combining RTS,S/AS01 malaria vaccine with Seasonal Malaria Chemoprevention
    Published: August 2021
    Statement
  2. PATH welcomes landmark financing agreement for GSK’s malaria vaccine
    Published: August 2021
    Statement
  3. PATH and Quansys Biosciences launch Q-Plex™ Human Environmental Enteric Dysfunction Diagnostic (11-Plex) to accelerate EED interventions
    Effective and affordable new research diagnostic tool can measure up to 11 key biomarkers of environmental enteric dysfunction with a single test
    Published: July 2021
    Press Release
  4. New partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide
    The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria.
    Published: July 2021
    Press Release
  5. PATH welcomes Dr. Lutz Hegemann to the board of directors
    Published: July 2021
    Press Release
Previous
Next